Discovery of novel potent covalent inhibitor-based EGFR degrader with excellent in vivo efficacy
Shi Shi(South China Agricultural University), Qihua Zhu(China Pharmaceutical University), Jing Niu(China Pharmaceutical University), Lei Huang(Therapeutics Clinical Research), Yungen Xu(China Pharmaceutical University), Yu Du(China Pharmaceutical University), Jiaqi Cui(China Pharmaceutical University)
Cited by 65
Related Papers
Safe and just Earth system boundaries
|Nature|2023|1.2k
A just world on a safe planet: a Lancet Planetary Health–Earth Commission report on Earth-system boundaries, translations, and transformations
|The Lancet Planetary Health|2024|144
Association between serum leptin levels and breast cancer risk
|Medicine|2018|103
Educational Data Mining Techniques for Student Performance Prediction: Method Review and Comparison Analysis
|Frontiers in Psychology|2021|103
MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner
|Cell Death and Disease|2017|92